MADISON BROWN: Open Payments
NPI 1760073993 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$716 in 33 payments from 11 companies in 2025. Trend: 2023 $665 · 2024 $1,122 · 2025 $716
Food & beverage: $716
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $234 |
| Lilly USA, LLC | 4 | $79 |
| Novo Nordisk Inc | 4 | $69 |
| AstraZeneca Pharmaceuticals LP | 3 | $66 |
| Sumitomo Pharma America, Inc. | 2 | $50 |
| Globus Medical, Inc. | 1 | $44 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $42 |
| Janssen Pharmaceuticals, Inc | 2 | $42 |
| PFIZER INC. | 2 | $38 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $30 |
Products named: QULIPTA, MOUNJARO, Ozempic, GEMTESA, AIRSUPRA, Senza, UBRELVY, JARDIANCE.
Industry payments across NC — which companies pay providers there.
